Literature DB >> 15921407

Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound.

Sabine Van Miert1, Steven Hostyn, Bert U W Maes, Kanyanga Cimanga, Reto Brun, Marcel Kaiser, Péter Mátyus, Roger Dommisse, Guy Lemière, Arnold Vlietinck, Luc Pieters.   

Abstract

The antiprotozoal activities of three naturally occurring isomeric indoloquinoline alkaloids, i.e., cryptolepine (1), neocryptolepine (2), and isocryptolepine (3), and two dimeric indoloquinoline alkaloids, cryptoquindoline (6) and biscryptolepine (7), originally obtained from the plant Cryptolepis sanguinolenta, were compared with those of a new synthetic indoloquinoline isomer, isoneocryptolepine (4), and a quaternary derivative, N-methyl-isocryptolepinium iodide (5). The latter compounds showed a high antiplasmodial activity against the chloroquine-resistant Plasmodium falciparum strain K1 (IC50 of 0.23 +/- 0.04 and 0.017 +/- 0.004 microM, respectively), while the cytotoxicity (L6 cells) was 4.32 +/- 0.04 and 12.7 +/- 2.0 microM, respectively. Isoneocryptolepine (4) was found to act as an inhibitor of beta-hematin formation and as a DNA-intercalating agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921407     DOI: 10.1021/np0496284

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

Review 1.  Isolation and synthesis of cryptosanguinolentine (isocryptolepine), a naturally-occurring bioactive indoloquinoline alkaloid.

Authors:  Elida N Thobokholt; Enrique L Larghi; Andrea B J Bracca; Teodoro S Kaufman
Journal:  RSC Adv       Date:  2020-05-19       Impact factor: 4.036

2.  Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.

Authors:  B A Iwalokun
Journal:  Afr Health Sci       Date:  2008-03       Impact factor: 0.927

3.  Identifying key intermediates generated in situ from Cu(II) salt-catalyzed C-H functionalization of aromatic amines under illumination.

Authors:  Qing-Yuan Meng; Xue-Wang Gao; Tao Lei; Zan Liu; Fei Zhan; Zhi-Jun Li; Jian-Ji Zhong; Hongyan Xiao; Ke Feng; Bin Chen; Ye Tao; Chen-Ho Tung; Li-Zhu Wu
Journal:  Sci Adv       Date:  2017-08-25       Impact factor: 14.136

4.  Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative.

Authors:  Kitiya Rujimongkon; Mathirut Mungthin; Jumreang Tummatorn; Sumate Ampawong; Poom Adisakwattana; Usa Boonyuen; Onrapak Reamtong
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

5.  Visible-Light-Mediated Aerobic Tandem Dehydrogenative Povarov/Aromatization Reaction: Synthesis of Isocryptolepines.

Authors:  Eva Schendera; Lisa-Natascha Unkel; Phung Phan Huyen Quyen; Gwen Salkewitz; Frank Hoffmann; Alexander Villinger; Malte Brasholz
Journal:  Chemistry       Date:  2019-11-27       Impact factor: 5.236

6.  A nitroalkane-based approach to one-pot three-component synthesis of isocryptolepine and its analogs with potent anti-cancer activities.

Authors:  Nicolai A Aksenov; Alexander V Aksenov; Alexander Kornienko; Annelise De Carvalho; Véronique Mathieu; Dmitrii A Aksenov; Sergei N Ovcharov; Georgii D Griaznov; Michael Rubin
Journal:  RSC Adv       Date:  2018-11-01       Impact factor: 3.361

7.  Synthesis and Evaluation of the Tetracyclic Ring-System of Isocryptolepine and Regioiso-Mers for Antimalarial, Antiproliferative and Antimicrobial Activities.

Authors:  Katja S Håheim; Emil Lindbäck; Kah Ni Tan; Marte Albrigtsen; Ida T Urdal Helgeland; Clémence Lauga; Théodora Matringe; Emily K Kennedy; Jeanette H Andersen; Vicky M Avery; Magne O Sydnes
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

8.  An efficient access to the synthesis of novel 12-phenylbenzo[6,7]oxepino[3,4-b]quinolin-13(6H)-one derivatives.

Authors:  Wentao Gao; Guihai Lin; Yang Li; Xiyue Tao; Rui Liu; Lianjie Sun
Journal:  Beilstein J Org Chem       Date:  2012-10-30       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.